Potential chemoprevention effect of dietary fucoxanthin on urinary bladder cancer EJ-1 cell line

Oncology Reports

Volumn 20, Issue 5, 2008, Pages 1099-1103

  Zhang, Zhenya ^a   Zhang, Peijuan ^a   Hamada, Michito ^a   Takahashi, Satoru ^a   Xing, Guoqing ^a   Liu, Jiqiang ^a   Sugiura, Norio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Antiproliferative effect; Apoptosis; Caspase 3 activity; Fucoxanthin, bladder cancer cell

Indexed keywords

CASPASE 3; DNA; FUCOXANTHIN; LAMINARIA JAPONICA EXTRACT; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; XANTHOPHYLL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LAMINARIA; LAMINARIA JAPONICA; PRIORITY JOURNAL; BLADDER TUMOR; CELL SURVIVAL; DIET; DRUG EFFECT; FLOW CYTOMETRY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOPREVENTION; DIET; FLOW CYTOMETRY; HUMANS; REACTIVE OXYGEN SPECIES; URINARY BLADDER NEOPLASMS; XANTHOPHYLLS;

EID: 58149350379     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000115     Document Type: Article

References (41)

1. Borden LS, Clark PE and Hall MC: Bladder cancer. Curr Opin Oncol 15: 227-233, 2003.
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al: Cancer statistics. CA Cancer J Clin 55: 10-30, 2005.
3. Riboli E, Gonzalez CA, Lopez-Abente G, et al: Diet and bladder cancer in Spain: a multi-centre case-control study. Int J Cancer 49: 214-219, 1991.
4. Bruemmer B, White E, Vaughan TL and Cheney CL: Nutrient intake in relation to bladder cancer among middle-aged men and women. Am J Epidemiol 144: 485-495, 1996.
5. Steineck G, Hagman U, Gerhardsson M and Norell SE: Vitamin A supplements, fried foods, fat and urothelial cancer, a case-referent study in Stockholm in 1985-1987. Int J Cancer 45: 1006-1011, 1990.
6. Steinmaus CM, Nunez S and Smith AH: Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol 151: 693-702, 2000.
7. Glade MJ: Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition 15: 523-526, 1999.
8. Nagano J, Kono S, Preston DL, Moriwaki H, Sharp GB, Koyama K, et al: Bladder-cancer incidence in relation to vegetable and fruit consumption: a prospective study of atomic-bomb survivors. Int J Cancer 86: 132-138, 2000.
9. Mokhtar NM, el-Aaser AA, el-Bolkainy MN, Ibrahim HA, el-Din NB and Moharram NZ: Effect of soybean feeding on experimental carcinogenesis-III. Carcinogenecity of nitrite and dibutylamine in mice: a histopathological study. Eur J Cancer Clin Oncol 24: 403-411, 1988.
10. Soloway MS, Cohen SM, Dekernion JB and Persky L: Failure of ascorbic acid to inhibit FANFT-induced bladder cancer. J Urol 113: 483-486, 1975.
11. Bruemmer B, White E, Vaughan TL and Cheney CL: Nutrient intake in relation to bladder cancer among middle-aged men and women. Am J Epidemiol 144: 485-495, 1996.
12. Jacobs EJ, Henion AK, Briggs PJ, et al: Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol 156: 1002-1010, 2002.
13. Sigounas G, Anagnostou A and Steiner M: dl-Alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr Cancer 28: 30-35, 1997.
14. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC and Giovannucci E: Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am J Epidemiol 152: 1145-1153, 2000.
15. Helzlsouer KJ, Comstock GW and Morris JS: Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res 49: 6144-6148, 1989.
16. Sun CL, Yuan JM, Wang XL, Gao YT, Ross RK and Yu MC: Dietary soy and increased risk of bladder cancer: a prospective cohort study of men in Shanghai, China. Int J Cancer 112: 319-323, 2004.
17. Goldbohm RA, Hertog MG, Brants HA, van Poppel G and van den Brandt PA: Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst 88: 93-100, 1996.
18. Sato D and Matsushima M: Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves. Int J Urol 10: 160-166, 2003.
19. Bianchi GD, Cerhan JR, Parker AS, et al: Tea consumption and risk of bladder and kidney cancers in a population-based case-control study. Am J Epidemiol 151: 377-383, 2000.
20. Lu CM, Lan SJ, Lee YH, Huang JK, Huang CH and Hsieh CC: Tea consumption: fluid intake and bladder cancer risk in Southern Taiwan. Urology 54: 823-828, 1999.
21. Haugan JA, Aakeman T and Liaaen-Jensen S: Example 2: macroalgae and microalgae. In: Carotenoids, Vol. 1A: Isolation and Analysis. Britton G, Liaaen-Jensen S and Pfander H (eds). Birkhäuser Verlag, Basel, pp215-226, 1995.
22. Konishi I, Hosokawa M, Sashima T, Kobayashi H and Miyashita K: Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells. Comp Biochem Physiol C Toxicol Pharmacol 142: 53-59, 2006.
23. Kotake-Nara E, Asai A and Nagao A: Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells. Cancer Lett 220: 75-84, 2005.
24. Kotake-Nara E, Terasaki M and Nagao A: Characterization of apoptosis induced by fucoxanthin in human promyelocytic leukemia cells. Biosci Biotechnol Biochem 69: 224-227, 2005.
25. Hosokawa M, Kudo M, Maeda H, Kohno H, Tanaka T and Miyashita K: Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells. Biochim Biophys Acta 1675: 113-119, 2004.
26. Murakami C, Takemura M, Sugiyama Y, et al: Vitamin A-related compounds, all-trans retinal and retinoic acids, selectively inhibit activities of mammalian replicative DNA polymerases. Biochim Biophys Acta 1574: 85-92, 2002.
27. Hosokawa M, Wanezaki S, Miyauchi K, et al: Apoptosis-inducing effect of fucoxanthin on human leukemia cell line HL-60. Food Sci Technol Res 5: 243-246, 1999.
28. Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K and Nagao A: Carotenoids affect proliferation of human prostate cancer cells. J Nutr 131: 3303-3306, 2001.
29. Compto MM: A biochemical hallmark of apoptosis: Inter-nucleosomal degradation of the genome. Cancer Metastasis Rev 11: 105-119, 1992.
30. Sugawara T, Matsubara K, Akagi R, Mori M and Hirata T: Antiangiogenic activity of brown algae fucoxnthin and its deacetylated product, fucoxanthinol. J Agric Food Chem 54: 9805-9810, 2006.
31. Danial NN and Korsmeyer SJ: Cell death: critical control points. Cell 116: 205-219, 2004.
32. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
33. Smets LA: Programmed cell death (apoptosis) and response to anti-cancer drugs. Anticancer Drugs 5: 3-9, 1994.
34. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326 (Pt 1): 1-16, 1997.
35. Pandey S, Smith B, Walker PR and Sikorska M: Caspase-dependent and independent cell death in rat hepatoma 5123tc cells. Apoptosis 5: 265-275, 2000.
36. Shi Y: Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9: 459-470, 2002.
37. Sumantran VN, Zhang R, Lee DS and Wicha MS: Differential regulation of apoptosis in normal versus transformed mammary epithelium by lutein and retinoic acid. Cancer Epidemiol Biomarkers Prev 9: 257-263, 2000.
38. Nara E, Hayashi H, Kotake M, Miyashita K and Nagao A: Acyclic carotenoids and their oxidation mixtures inhibit the growth of HL-60 human promyelocytic leukemia cells. Nutr Cancer 39: 273-283, 2001.
39. Muller K, Carpenter KLH, Challis IR, Skepper JN and Arends MJ: Carotenoids induce apoptosis in the T-lymphoblast cell line Jurkat E6.1. Free Radic Res 36: 791-802, 2002.
40. Asai A, Sugawara T, Ono H and Nagao A: Biotransformation of fucoxanthinol into ammmarouciaxanthin a in mice and HepG2 cells: Formation and cytotoxicity of fucoxanthin metabolite. Drug Metab Dispos 32: 205-211, 2004.
41. Ikemoto S, Sugimura K, Yoshida N, Yasumoto R, Wada S, Yamamoto K and Kishimoto T: Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 55: 951-955, 2000.